Universe Pharmaceuticals Inc.
UPC · NASDAQ
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $29 | $5 | $6 | $8 |
| Short-Term Investments | $0 | $13 | $13 | $14 |
| Receivables | $18 | $11 | $15 | $16 |
| Inventory | $2 | $3 | $2 | $2 |
| Other Curr. Assets | $3 | $4 | $5 | $10 |
| Total Curr. Assets | $52 | $37 | $42 | $50 |
| Property Plant & Equip (Net) | $15 | $15 | $14 | $15 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $1 | $1 | $1 | $1 |
| Tax Assets | $0 | $1 | $1 | $1 |
| Other NC Assets | $0 | $0 | $2 | $2 |
| Total NC Assets | $16 | $16 | $18 | $20 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $68 | $53 | $60 | $70 |
| Liabilities | – | – | – | – |
| Payables | $5 | $5 | $3 | $5 |
| Short-Term Debt | $6 | $5 | $4 | $4 |
| Tax Payable | $1 | $0 | $0 | $1 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $9 | $3 | $6 | $0 |
| Total Curr. Liab. | $20 | $14 | $13 | $11 |
| LT Debt | $2 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $2 | $0 | $7 | $0 |
| Other Liabilities | $0 | $0 | -$7 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $22 | $14 | $13 | $11 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$10 | $10 | $16 | $25 |
| AOCI | $1 | $0 | $1 | $5 |
| Other Equity | $54 | $29 | $29 | $29 |
| Total Equity | $46 | $40 | $46 | $59 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $68 | $53 | $60 | $70 |
| Net Debt | -$22 | $0 | -$2 | -$4 |